牙科和上颚部手术

        目前没有新药被批准.

皮肤病和整型外科

内分泌

• Somatuline Depot (lanreotide acetate)用于治疗肢端肥大症和巨人症 Beaufour Ipsen公司生产; 2007年8月批准
• Evamist (estradiol); For the treatment of moderate to severe vasomotor symptoms due to menopause; Vivus; Approved July 2007
• Fenofibrate; 治疗高脂血症, 血脂异常和高甘油三酯血症 LifeCycle Pharma 生产, 2007年8月批准
• Supprelin LA (histrelin acetate); For the treatment of central precocious puberty; Indevis Pharms; Approved May 2007

消化系

目前没有新药被批准.

血液病

• Soliris (eculizumab); 用于治疗阵发性睡眠性血红蛋白尿症; Alexion Pharm; 2007年3月批准

免疫学和感染性疾病

• Doribax (doripenem); 用于治疗腹内,尿道感染; 强生公司生产, 2007 年10月批准
• Isentress (raltegravir); 用于治疗艾滋病感染 默克公司生产; 2007 年10月批准
• Altabax (retapamulin); For the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes; Glaxo; Approved April 2007
• AzaSite (azithromycin); For the treatment of bacterial conjunctivitis; InSite Vision; Approved April 2007
• Extina (ketoconazole); For the treatment of seborrheic dermatitis; Stiefel; Approved June 2007
• Selzentry (maraviroc); For the treatment of CCR5-tropic HIV-1; Pfizer; Approved August 2007
• Veramyst (fluticasone furoate); For the treatment of seasonal and perennial allergic rhinitis; GlaxoSmithKline; Approved April 2007
• Xyzal (levocetirizine dihydrochloride); For the treatment of seasonal and perennial allergic rhinitis and urticaria; UCB Inc.; Approved May 2007

目前没有新药被批准.

肌肉骨骼

• Evista (raloxifene hydrochloride); For the treatment/prevention of osteoporosis and reduction of breast cancer risk in postmenopausal women; Eli Lilly; Approved September 2007
• Reclast (zoledronic acid); For the treatment of postmenopausal osteoporosis; Novartis; Approved August 2007
• Reclast (zoledronic acid); For the treatment of Paget's disease; Novartis Pharms; Approved April 2007
• Somatuline Depot (lanreotide acetate); For the treatment of acromegaly; Beaufour Ipsen; Approved August 2007
  　

肾病和泌尿系

• Doribax (doripenem); For the treatment of intra-abdominal infections and urinary tract infections; Johnson & Johnson; Approved October 2007
• Mircera (methoxy polyethylene glycol-epoetin beta); For the treatment of anemia associated with chronic renal failure; Hoffman La-Roche; Approved November 2007
• Torisel (temsirolimus); For the treatment of renal cell carcinoma; Wyeth Pharms; Approved May 2007
  　

　

神经

• Vyvanse (Lisdexamfetamine Dimesylate); 用于治疗注意力不集中/过动症; New River; 2007年2月批准

• Exelon (rivastigmine tartrate); For the treatment of Alzheimer's and Parkinson's disease-related dementia; Novartis Pharms; Approved July 2007
• Neupro (rotigotine); For the treatment of Parkinson's disease; Schwarz; Approved May 2007
• Nuvigil (armodafinil); For the treatment of excessive sleepiness; Cephalon; Approved June 2007

　

妇产科

       

• Evamist (estradiol); For the treatment of moderate to severe vasomotor symptoms due to menopause; Vivus; Approved July 2007
• Evista (raloxifene hydrochloride); For the treatment/prevention of osteoporosis and reduction of breast cancer risk in postmenopausal women; Eli Lilly; Approved September 2007
• Reclast (zoledronic acid); For the treatment of postmenopausal osteoporosis; Novartis; Approved August 2007
  　

肿瘤

• Torisel (temsirolimus); For the treatment of renal cell carcinoma; Wyeth Pharms; Approved May 2007
• Evista (raloxifene hydrochloride); For the treatment/prevention of osteoporosis and reduction of breast cancer risk in postmenopausal women; Eli Lilly; Approved September 2007
• Hycamtin (topotecan); For the treatment of small cell lung cancer; GlaxoSmithKline; Approved October 2007
• Ixempra (ixabepilone); For the treatment of breast cancer; Bristol Myers Squibb; Approved October 2007
• Tasigna (nilotinib hydrochloride monohydrate); For the treatment of chronic myelogenous leukemia; Novartis; Approved October 2007
• Tykerb (lapatinib); 用于治疗乳腺癌的治疗; GlaxoSmithKline; 2007年3月批准

　

眼科

• AzaSite (azithromycin); For the treatment of bacterial conjunctivitis; InSite Vision; Approved April 2007

　

耳鼻喉科

• Veramyst (fluticasone furoate); For the treatment of seasonal and perennial allergic rhinitis; GlaxoSmithKline; Approved April 2007
• Xyzal (levocetirizine dihydrochloride); For the treatment of seasonal and perennial allergic rhinitis and urticaria; UCB Inc.; Approved May 2007

　

儿科

• Altabax (retapamulin); For the treatment of impetigo due to Staphylococcus aureus or Streptococcus pyogenes; Glaxo; Approved April 2007

• Supprelin LA (histrelin acetate); For the treatment of central precocious puberty; Indevis Pharms; Approved May 2007
• Veramyst (fluticasone furoate); For the treatment of seasonal and perennial allergic rhinitis; GlaxoSmithKline; Approved April 2007
• Xyzal (levocetirizine dihydrochloride); For the treatment of seasonal and perennial allergic rhinitis and urticaria; UCB Inc.; Approved May 2007
• Zingo (lidocaine hydrochloride monohydrate); For local analgesia prior to venipuncture or peripheral intravenous cannulation, in children 3 to 18 years of age; Anesiva; Approved August 2007

• Vyvanse (Lisdexamfetamine Dimesylate); 用于治疗注意力不集中/过动症; New River; 2007年2月批准

　

药理和中毒

目前没有新药被批准

精神, 心理

• Vyvanse (Lisdexamfetamine Dimesylate); 用于治疗注意力不集中/过动症; New River; 2007年2月批准

　

呼吸道和肺疾病

• Letairis (ambrisentan); For the treatment of pulmonary arterial hypertension; Gilead; Approved June 2007
• Xyzal (levocetirizine dihydrochloride); For the treatment of seasonal and perennial allergic rhinitis and urticaria; UCB Inc.; Approved May 2007

　

类风湿

• 目前没有新药被批准.

　

外伤和急救医学

目前没有新药被批准